Virtual Reality Intradialysis: Last vs. First Part of the Session

Status Recruiting

Clinical Trial Summary

The main objective of this investigation is to assess if an intradialysis virtual reality exercise program during the last two hours of the hemodialysis session results in greater hemodynamic stability than exercise performed during the first two hours of the hemodialysis session. The secondary aims are to assess the impact of intradialysis virtual reality exercise during the last two hours of the hemodialysis session on dialysis efficacy, postdialysis molecules rebound, adherence to exercise, functional capacity, physical activity level, health-related quality of life, cognitive function, morbidity, frailty and dependency. We will also analyze the reliability of muscle strength assessment of lower limb muscles with a handheld dynamometer during hemodialysis.

Clinical Trial Description

Participants will be randomized into one of two groups. The first group will perform a virtual reality exercise during the first two hours of the hemodialysis session. The second group will perform a virtual reality exercise during the last two hours of the hemodialysis session. The exercise program will last for 9 months. The virtual reality exercise will undertake up to 30 minutes of exercise. After warming up, participants will play to an adapted 'treasure hunt' game. Their legs movements will be the players projected into an individual tv that will give them feedback regarding their achievements. The aim of the game will be to achieve the higher possible score. They will move their legs to pick up coins and to avoid bombs. An adapted Kinect technology will be used for game development. The exercise session will end-up with a cool-down period that will include simple lower limb stretching exercises. Two more games will be introduced progressively for patients not to get bored, 'Air Hockey' and 'Simon'. ;

Study Design

Related Conditions & MeSH terms

End Stage Renal Disease on Dialysis
Hemodialysis Complication
Kidney Failure, Chronic

Clinical Trial Details

NCT number	NCT04046042
Study type	Interventional
Source	Cardenal Herrera University
Contact	Eva Segura-Ortí, PhD
Phone	00 34 671580094
Email	eva.segura@gmail.com
Status	Recruiting
Phase	N/A
Start date	September 2, 2019
Completion date	August 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05980845` - The Effect Nature Sounds and Music on Hemodialysis Patients	N/A
Recruiting	`NCT05020717` - Retrospective Survey of Hyperkalemia in Hemodialysis
Recruiting	`NCT04094038` - The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients	Phase 4
Completed	`NCT03311581` - The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery	Phase 1
Completed	`NCT05531175` - REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS	N/A
Completed	`NCT04057313` - Coffee in Hemodialysis and Headache	N/A
Completed	`NCT03061552` - Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life	N/A
Completed	`NCT03251573` - The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
Completed	`NCT05568342` - The Effect of Roy Adaptation-Based Nursing Intervention	N/A
Completed	`NCT03527680` - Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis	N/A
Completed	`NCT04063423` - Non- Clinical Coagulation Activation During Hemodialysis
Active, not recruiting	`NCT06203795` - Dialysis Performance of the FX CorAL Membrane	N/A
Completed	`NCT04319328` - Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
Completed	`NCT03627884` - Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation	Phase 4
Completed	`NCT05132036` - Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients	N/A
Completed	`NCT03076528` - An Innovative Virtually Supervised Exercise for Dialysis Patients	Phase 2
Completed	`NCT06098443` - Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis	N/A
Completed	`NCT04645121` - Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
Recruiting	`NCT04127877` - Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients	N/A
Recruiting	`NCT04563091` - Potassium Kinetic During and After Hemodialysis and Potassium Profiling to Prevent Arrhythmias	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Virtual Reality Intradialysis: Last vs. First Part of the Session — VRI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms